Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals

Corinne Pettigrew, Anja Soldan, Yuxin Zhu, Qing Cai, Mei Cheng Wang, Abhay Moghekar, Michael I. Miller, Baljeet Singh, Oliver Martinez, Evan Fletcher, Charles DeCarli, Marilyn Albert

Research output: Contribution to journalArticle

Abstract

We examined whether cognitive reserve (CR) impacts level of, or rate of change in, biomarkers of Alzheimer's disease (AD) and small-vessel cerebrovascular disease in >250 individuals who were cognitively normal and middle-aged and older at the baseline. The four primary biomarker categories commonly examined in studies of AD were measured longitudinally: cerebrospinal fluid measures of amyloid (A) and tau (T); cerebrospinal fluid and neuroimaging measures of neuronal injury (N); and neuroimaging measures of white matter hyperintensities (WMHs) to assess cerebrovascular pathology (V). CR was indexed by a composite score including years of education, reading, and vocabulary test performance. Higher CR was associated with lower levels of WMHs, particularly among those who subsequently progressed from normal cognition to MCI. CR was not associated with WMH trajectories. In addition, CR was not associated with either levels of, or rate of change in, A/T/N biomarkers. This may suggest that higher CR is associated with lifestyle factors that reduce levels of cerebrovascular disease, allowing individuals with higher CR to better tolerate other types of pathology.

Original languageEnglish (US)
JournalNeurobiology of aging
DOIs
StateAccepted/In press - Jan 1 2020

Fingerprint

Cognitive Reserve
Cerebrovascular Disorders
Alzheimer Disease
Biomarkers
Neuroimaging
Cerebrospinal Fluid
Pathology
Language Tests
Amyloid
Cognition
Life Style
Reading
Education
Wounds and Injuries

Keywords

  • Alzheimer's disease
  • Amyloid
  • Biomarkers
  • Cerebrovascular disease
  • Cognitive reserve
  • Tau

ASJC Scopus subject areas

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals. / Pettigrew, Corinne; Soldan, Anja; Zhu, Yuxin; Cai, Qing; Wang, Mei Cheng; Moghekar, Abhay; Miller, Michael I.; Singh, Baljeet; Martinez, Oliver; Fletcher, Evan; DeCarli, Charles; Albert, Marilyn.

In: Neurobiology of aging, 01.01.2020.

Research output: Contribution to journalArticle

Pettigrew, Corinne ; Soldan, Anja ; Zhu, Yuxin ; Cai, Qing ; Wang, Mei Cheng ; Moghekar, Abhay ; Miller, Michael I. ; Singh, Baljeet ; Martinez, Oliver ; Fletcher, Evan ; DeCarli, Charles ; Albert, Marilyn. / Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals. In: Neurobiology of aging. 2020.
@article{f205e718f02240fcbd203c8ff47368c4,
title = "Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals",
abstract = "We examined whether cognitive reserve (CR) impacts level of, or rate of change in, biomarkers of Alzheimer's disease (AD) and small-vessel cerebrovascular disease in >250 individuals who were cognitively normal and middle-aged and older at the baseline. The four primary biomarker categories commonly examined in studies of AD were measured longitudinally: cerebrospinal fluid measures of amyloid (A) and tau (T); cerebrospinal fluid and neuroimaging measures of neuronal injury (N); and neuroimaging measures of white matter hyperintensities (WMHs) to assess cerebrovascular pathology (V). CR was indexed by a composite score including years of education, reading, and vocabulary test performance. Higher CR was associated with lower levels of WMHs, particularly among those who subsequently progressed from normal cognition to MCI. CR was not associated with WMH trajectories. In addition, CR was not associated with either levels of, or rate of change in, A/T/N biomarkers. This may suggest that higher CR is associated with lifestyle factors that reduce levels of cerebrovascular disease, allowing individuals with higher CR to better tolerate other types of pathology.",
keywords = "Alzheimer's disease, Amyloid, Biomarkers, Cerebrovascular disease, Cognitive reserve, Tau",
author = "Corinne Pettigrew and Anja Soldan and Yuxin Zhu and Qing Cai and Wang, {Mei Cheng} and Abhay Moghekar and Miller, {Michael I.} and Baljeet Singh and Oliver Martinez and Evan Fletcher and Charles DeCarli and Marilyn Albert",
year = "2020",
month = "1",
day = "1",
doi = "10.1016/j.neurobiolaging.2019.12.003",
language = "English (US)",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals

AU - Pettigrew, Corinne

AU - Soldan, Anja

AU - Zhu, Yuxin

AU - Cai, Qing

AU - Wang, Mei Cheng

AU - Moghekar, Abhay

AU - Miller, Michael I.

AU - Singh, Baljeet

AU - Martinez, Oliver

AU - Fletcher, Evan

AU - DeCarli, Charles

AU - Albert, Marilyn

PY - 2020/1/1

Y1 - 2020/1/1

N2 - We examined whether cognitive reserve (CR) impacts level of, or rate of change in, biomarkers of Alzheimer's disease (AD) and small-vessel cerebrovascular disease in >250 individuals who were cognitively normal and middle-aged and older at the baseline. The four primary biomarker categories commonly examined in studies of AD were measured longitudinally: cerebrospinal fluid measures of amyloid (A) and tau (T); cerebrospinal fluid and neuroimaging measures of neuronal injury (N); and neuroimaging measures of white matter hyperintensities (WMHs) to assess cerebrovascular pathology (V). CR was indexed by a composite score including years of education, reading, and vocabulary test performance. Higher CR was associated with lower levels of WMHs, particularly among those who subsequently progressed from normal cognition to MCI. CR was not associated with WMH trajectories. In addition, CR was not associated with either levels of, or rate of change in, A/T/N biomarkers. This may suggest that higher CR is associated with lifestyle factors that reduce levels of cerebrovascular disease, allowing individuals with higher CR to better tolerate other types of pathology.

AB - We examined whether cognitive reserve (CR) impacts level of, or rate of change in, biomarkers of Alzheimer's disease (AD) and small-vessel cerebrovascular disease in >250 individuals who were cognitively normal and middle-aged and older at the baseline. The four primary biomarker categories commonly examined in studies of AD were measured longitudinally: cerebrospinal fluid measures of amyloid (A) and tau (T); cerebrospinal fluid and neuroimaging measures of neuronal injury (N); and neuroimaging measures of white matter hyperintensities (WMHs) to assess cerebrovascular pathology (V). CR was indexed by a composite score including years of education, reading, and vocabulary test performance. Higher CR was associated with lower levels of WMHs, particularly among those who subsequently progressed from normal cognition to MCI. CR was not associated with WMH trajectories. In addition, CR was not associated with either levels of, or rate of change in, A/T/N biomarkers. This may suggest that higher CR is associated with lifestyle factors that reduce levels of cerebrovascular disease, allowing individuals with higher CR to better tolerate other types of pathology.

KW - Alzheimer's disease

KW - Amyloid

KW - Biomarkers

KW - Cerebrovascular disease

KW - Cognitive reserve

KW - Tau

UR - http://www.scopus.com/inward/record.url?scp=85077693806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077693806&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2019.12.003

DO - 10.1016/j.neurobiolaging.2019.12.003

M3 - Article

AN - SCOPUS:85077693806

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

ER -